VTVT — vTv Therapeutics Inc · rev $36.8M

vTv Therapeutics Inc (VTVT) is a biotechnology company listed on NASDAQ.

Latest reported VTVT revenue for 2026-06-30 was $36.8M. Net income was $11.1M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. VTVT currently screens at market cap $133.9M.

Use this VTVT page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the VTVT quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the VTVT SEC filings page. Lician reads the product cache first so this HTML stays unique to vTv Therapeutics Inc even when a live quote feed is slow.

vTv Therapeutics Inc latest statements (FY2025)

Latest cached year on this hub. Full VTVT income, balance, and cash tables.

  • Revenue$0
  • Net Income-$27.0M
  • Total Assets$89.9M
  • Total Debt$0
  • Free Cash Flow$0

VTVT recent filings